Delivery Order SPE2DR25D2102-SPE2DR26FB2MW
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,138,309 units of TUBERSOL 5T UNIT/0.1 ML VIAL medication. The $1,075.20 contract has a completion date of December 20, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has previously received multiple DLA contracts to supply pharmaceuticals, medical supplies, and related distribution services to support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.60, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 19, 2024. The contract was awarded on November 18, 2024 and does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial 5ML with a ceiling value of $1,069.88 under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and no set-aside designation was utilized. Performance will be conducted at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,683.44 order is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML pharmaceutical products to support DLA Troop Support Medical programs and facilities. No set aside designation was used for this contract. Amerisourcebergen Drug Corp has an extensive...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML. The award has a ceiling value of $2,141.90 and an ultimate completion date of April 4, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The firm fixed price delivery order has a potential value of $1,198.12 and a performance completion date of January 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML. The contract has a ceiling value of $2,529.24 and a completion date of September 27, 2024. It is a firm fixed-price contract without any set-aside designation. Amerisourcebergen is the prime contractor, and this award appears to be associated with a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,150 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Tubersol 5T units. As the prime contractor, Amerisourcebergen will supply 0.1 ml vials of the tuberculosis vaccine to fulfill requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. The Defense Logistics Agency functions as the logistics combat support agency for the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,150.40 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 5,000 units of Tubersol 5T vaccine in 0.1 ml vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by October 30, 2023. No set-aside designation was applied to this order, which was awarded against an existing...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2MWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,075.70 to AmerisourceBergen Drug Corp for Tubersol 5T Unit tuberculin skin test vials (0.1 mL, 5 mL) with a completion date of January 15, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order was awarded on January 14, 2026, and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle running through December 2026 that provides global pharmaceutical and medical supply support to military healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and other government healthcare systems. The company supplies a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities through competitively awarded contracts. This particular task order for tuberculin skin test reagent reflects the company's role in supporting preventive health programs within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/13/26 |